TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9652236

Group type: EXPERIMENTAL
Intervention: High voltage pulsed current (HVPC) in an energized wrist splint
Number of subjects: 120

Group type: COMPARATOR
Intervention: Non-energized unit in an identical splint (Control)
Number of subjects: 120
Study: 10335187

Group type: EXPERIMENTAL
Intervention: Patient goal setting and interdisciplinary collaboration and support
Number of subjects: 0
Study: 1852905

Group type: EXPERIMENTAL
Intervention: Continuous hyperfractionated accelerated radiotherapy (CHART)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Conventional radiotherapy
Number of subjects: 15
Study: 6686456

Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31949295

Group type: EXPERIMENTAL
Intervention: WW with diabetes counseling
Number of subjects: 563

Group type: COMPARATOR
Intervention: SC
Number of subjects: 563

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 563
Study: 31115552

Group type: EXPERIMENTAL
Intervention: Nutraceutical supplements (NS)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 47
Study: 30059775

Group type: EXPERIMENTAL
Intervention: True acupuncture (Group 1)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Sham acupuncture (Group 2)
Number of subjects: 34
Study: 26808861

Group type: EXPERIMENTAL
Intervention: Long warm-up (20 minutes: LWup)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Short warm-up (10 minutes: SWup)
Number of subjects: 10
Study: 24615075

Group type: EXPERIMENTAL
Intervention: Rehabilitation exercise + mosapride
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Rehabilitation exercise
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Mosapride
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 80
Study: 22460927

Group type: EXPERIMENTAL
Intervention: BRIDGES peer‐led education intervention
Number of subjects: 428

Group type: COMPARATOR
Intervention: services as usual wait list (control condition)
Number of subjects: 428
Study: 20051371

Group type: EXPERIMENTAL
Intervention: Oral DFMO (500 mg/m2/day)
Number of subjects: 291

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 291
Study: 16569396

Group type: EXPERIMENTAL
Intervention: Acceptance group
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Suppression group
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Spontaneous coping group
Number of subjects: 219
Study: 16340560

Group type: EXPERIMENTAL
Intervention: Percutaneous cholecystostomy followed by early laparoscopic cholecystectomy (PCLC)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conservative treatment followed by delayed laparoscopic cholecystectomy (DLC)
Number of subjects: 61
Study: 11882102

Group type: EXPERIMENTAL
Intervention: Ancrod treatment
Number of subjects: 495

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 495
Study: 9296896

Group type: EXPERIMENTAL
Intervention: Histamine challenge (n = 11)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Grass pollen antigen challenge (n = 8)
Number of subjects: 24

Group type: COMPARATOR
Intervention: PBS control (n = 5)
Number of subjects: 24
Study: 8320928

Group type: EXPERIMENTAL
Intervention: Polyamide membrane
Number of subjects: 10

Group type: COMPARATOR
Intervention: Polyacrylonitrile membrane
Number of subjects: 10
Study: 3636340

Group type: EXPERIMENTAL
Intervention: Timentin (ticarcillin 3 g plus potassium clavulanate 200 mg)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Piperacillin (125-200 mg/kg per day)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Timentin and Piperacillin (both groups)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Timentin
Number of subjects: 78

Group type: COMPARATOR
Intervention: Piperacillin
Number of subjects: 78
Study: 29229498

Group type: EXPERIMENTAL
Intervention: Once-daily, modified-release hydrocortisone
Number of subjects: 89

Group type: COMPARATOR
Intervention: Standard glucocorticoid therapy
Number of subjects: 89
Study: 25829064

Group type: EXPERIMENTAL
Intervention: Laparoscopic anterior 120° fundoplication (APF)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Total fundoplication (Nissen)
Number of subjects: 72
Study: 23818505

Group type: EXPERIMENTAL
Intervention: Writing about personal life goals
Number of subjects: 68

Group type: COMPARATOR
Intervention: Control topic writing
Number of subjects: 68
Study: 22276959

Group type: EXPERIMENTAL
Intervention: Drug Burden Index (DBI) low category (n=260)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Drug Burden Index (DBI) high category (n=153)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: Exposure to anticholinergic medication (33.6%) and sedative medications (41.9%)
Number of subjects: 602

Group type: EXPERIMENTAL
Intervention: All-cause mortality after follow-up (774-1269 days)
Number of subjects: 602
Study: 20176120

Group type: EXPERIMENTAL
Intervention: NREM-only daytime nap (n=14)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Equivalent waking period (n=17)
Number of subjects: 31
Study: 19011281

Group type: EXPERIMENTAL
Intervention: Alpha-linolenic acid (ALA) 6.0 g/day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) 2.8 g/day
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid (DHA) 2.9 g/day
Number of subjects: 48
Study: 16433210

Group type: EXPERIMENTAL
Intervention: Parietaria depot extract at 25 BU/mL (1.5 microg/mL Par j 1)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 12575905

Group type: EXPERIMENTAL
Intervention: HIGH-FAT diet (50 % fat, >34 % monounsaturated fatty acids)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: SUCROSE diet (high carbohydrate increase of 90 g sucrose/d)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: HIGH-GI diet (high-carbohydrate, high-GI)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: LOW-GI diet (high-carbohydrate, low-GI)
Number of subjects: 17
Study: 10656230

Group type: EXPERIMENTAL
Intervention: Increasing sulphonylurea dosages
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Adding metformin
Number of subjects: 174
Study: 8876776

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alpha-tocopherol (2,000 IU/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1464539

Group type: EXPERIMENTAL
Intervention: Illness Episode Approach (IEA) workshops
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional comparative information workshops
Number of subjects: 0
Study: 3882509

Group type: EXPERIMENTAL
Intervention: Branched chain amino acids
Number of subjects: 22

Group type: COMPARATOR
Intervention: Casein
Number of subjects: 22
Study: 30133940

Group type: EXPERIMENTAL
Intervention: Olfactory stimulation during reminiscence practice, bi-weekly for eight sessions
Number of subjects: 72

Group type: COMPARATOR
Intervention: No olfactory stimulation during reminiscence practice
Number of subjects: 72
Study: 27676156

Group type: EXPERIMENTAL
Intervention: Exercise + Honey Supplementation (70g, ninety minutes before each training session)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Exercise (Control)
Number of subjects: 24
Study: 24941816

Group type: EXPERIMENTAL
Intervention: Ketamine 1 mg/(kg x h)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Ketamine 0.5 mg/(kg x h)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 100
Study: 22156910

Group type: EXPERIMENTAL
Intervention: Educational board game
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (health talk)
Number of subjects: 180
Study: 20621660

Group type: EXPERIMENTAL
Intervention: 200 mg OpunDia
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 19061694

Group type: EXPERIMENTAL
Intervention: ezetimibe/simvastatin 10/40 mg
Number of subjects: 18000

Group type: COMPARATOR
Intervention: simvastatin monotherapy 40 mg
Number of subjects: 18000
Study: 16195202

Group type: EXPERIMENTAL
Intervention: Phonological awareness therapy (12 hours of therapy)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (untreated)
Number of subjects: 20
Study: 12391494

Group type: EXPERIMENTAL
Intervention: High-dose intravenous prednisone in combination with intramuscular polyvitaminic therapy (group A)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Polyvitaminic therapy alone (group B)
Number of subjects: 62
Study: 10216057

Group type: EXPERIMENTAL
Intervention: Macular hole group
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 10
Study: 7818255

Group type: EXPERIMENTAL
Intervention: Low-dose (7.5 mg) oral methotrexate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 2363111

Group type: EXPERIMENTAL
Intervention: Disodium monofluorophosphate with calcium salts (100 mg disodium monofluorophosphate, 500 mg calcium)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control preparation (not specified)
Number of subjects: 12
Study: 145441

Group type: EXPERIMENTAL
Intervention: Mithramycin (15 micrograms per kilogram of body weight per day)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Calcitonin combined with mithramycin
Number of subjects: 27

Group type: COMPARATOR
Intervention: Glucagon
Number of subjects: 27
Study: 31904874

Group type: EXPERIMENTAL
Intervention: Flexible distal‐chip laryngoscopy (FDL)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Rigid telescopic laryngoscopy (RTL)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Clinicians' assessment of discomfort for FDL
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Preference between FDL and RTL
Number of subjects: 23
Study: 30748011

Group type: EXPERIMENTAL
Intervention: Anastrozole (6-year group)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Anastrozole (3-year group)
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Bisphosphonate addition after anastrozole
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: Bisphosphonates after anastrozole cessation
Number of subjects: 910

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 910
Study: 28734759

Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks until disease progression, death, unacceptable toxic effects, or withdrawal from study.
Number of subjects: 74
Study: 25887365

Group type: EXPERIMENTAL
Intervention: Non-pharmacological multidisciplinary face-to-face treatment program (6 weeks, 7 group sessions)
Number of subjects: 147

Group type: COMPARATOR
Intervention: Telephone-based treatment program (6 weeks, 2 group sessions + 4 telephone contacts)
Number of subjects: 147

Group type: EXPERIMENTAL
Intervention: Non-pharmacological multidisciplinary face-to-face treatment program
Number of subjects: 147

Group type: COMPARATOR
Intervention: Telephone-based treatment program
Number of subjects: 147
Study: 24395994

Group type: EXPERIMENTAL
Intervention: General lifestyle content (Tx1)
Number of subjects: 1698

Group type: EXPERIMENTAL
Intervention: Personally tailored health information (Tx2)
Number of subjects: 1698

Group type: EXPERIMENTAL
Intervention: Personally tailored health information plus online video-based peer coaching (Tx3)
Number of subjects: 1698

Group type: EXPERIMENTAL
Intervention: Intervention groups (Tx1, Tx2, Tx3)
Number of subjects: 1698
Study: 20723799

Group type: EXPERIMENTAL
Intervention: Sertraline 50 to 200 mg/day
Number of subjects: 469

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 469

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 469
Study: 18959553

Group type: EXPERIMENTAL
Intervention: Informational advertisement regarding disease symptoms
Number of subjects: 413

Group type: COMPARATOR
Intervention: NZ direct-to-consumer advertisements (DTCA)
Number of subjects: 413

Group type: COMPARATOR
Intervention: Other Australian advertisements
Number of subjects: 413

Group type: COMPARATOR
Intervention: Emotive and transformational advertisements
Number of subjects: 413
Study: 15845716

Group type: EXPERIMENTAL
Intervention: Posterior popliteal approach (Group 1)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Labat's approach (Group 2)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 120
Study: 12810178

Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (nonusers of HRT)
Number of subjects: 80
Study: 10554734

Group type: EXPERIMENTAL
Intervention: Accessing centralized databases for zipcode-level income information
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Location of participating center in the 'stroke belt' (southeastern United States)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Socioeconomic patterns analysis
Number of subjects: 0
Study: 9093645

Group type: EXPERIMENTAL
Intervention: Diazepam 100 micrograms/kg (Group DS)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Sufentanil anesthesia (Group S)
Number of subjects: 16
Study: 1746459

Group type: EXPERIMENTAL
Intervention: Exercise training for 1 year using the Canadian Airforce plan for physical fitness
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study: 6757621

Group type: EXPERIMENTAL
Intervention: Polyunsaturated phosphatidyl choline therapy (3 g/day)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Normal maintenance immunosuppressive therapy
Number of subjects: 15
Study: 28888762

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (Streptococcus thermophilus, Lactobacillus acidophilus, Bifidobacterium longum, 90 billion colony-forming units per day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 26259908

Group type: EXPERIMENTAL
Intervention: Mini in vitro fertilization (single embryo transfer)
Number of subjects: 564

Group type: COMPARATOR
Intervention: Conventional in vitro fertilization (double embryo transfer)
Number of subjects: 564

Group type: EXPERIMENTAL
Intervention: Mini in vitro fertilization
Number of subjects: 564

Group type: COMPARATOR
Intervention: Conventional in vitro fertilization
Number of subjects: 564
Study: 24099432

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral (CB) group
Number of subjects: 378

Group type: COMPARATOR
Intervention: CB bibliotherapy
Number of subjects: 378

Group type: COMPARATOR
Intervention: Brochure control
Number of subjects: 378
Study: 22893167

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral conjoint therapy for PTSD (15 sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 80
Study: 19922797

Group type: EXPERIMENTAL
Intervention: Post-PCI statin therapy
Number of subjects: 2979
Study: 18612008

Group type: EXPERIMENTAL
Intervention: Highly cross‐linked, e‐beamed, melted polyethylene
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional polyethylene sterilized by gamma irradiation in air
Number of subjects: 0
Study: 16914473

Group type: EXPERIMENTAL
Intervention: Earlier treatment with peripheral retinal ablation
Number of subjects: 339

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 339
Study: 12822837

Group type: EXPERIMENTAL
Intervention: Grouping of trials (Block 1 vs Block 2)
Number of subjects: 0
Study: 10639356

Group type: EXPERIMENTAL
Intervention: Teicoplanin (TEC) 400 mg in 100 ml of saline as a 5‐min infusion into a foot vein of the leg to be operated on, administered immediately after the tourniquet was inflated to 400 mm Hg.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Teicoplanin (TEC) administered for bilateral TKR, with regional administration repeated for the second knee operation.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Teicoplanin (TEC) administered in monolateral and bilateral TKR.
Number of subjects: 160
Study: 8895288

Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 60

Group type: COMPARATOR
Intervention: Atracurium
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cisatracurium after neostigmine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Atracurium after neostigmine
Number of subjects: 60
Study: 1906399

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ursodiol (1200 mg/day)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Aspirin (1300 mg/day)
Number of subjects: 34
Study: 6614965

Group type: EXPERIMENTAL
Intervention: 20% 5-fluorouracil (5-FU) ointment applied topically for four weeks
Number of subjects: 0
Study: 30234853

Group type: EXPERIMENTAL
Intervention: Study Eye (SE) after ERM surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Fellow Eye (FE) as control
Number of subjects: 20
Study: 29957615

Group type: EXPERIMENTAL
Intervention: Therapeutic vaccines
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination approaches in nonhuman primates
Number of subjects: 0
Study: 27257003

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training once daily 5 days/week for 2 weeks in addition to usual care
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training
Number of subjects: 70
Study: 24574902

Group type: EXPERIMENTAL
Intervention: Single education and counseling intervention (45-minute session 48 hours before HSG)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 217
Study: 22191426

Group type: EXPERIMENTAL
Intervention: 1 mg 17β‐estradiol in smokers
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: 1 mg 17β‐estradiol in non-smokers
Number of subjects: 244

Group type: EXPERIMENTAL
Intervention: Estrogen group (1 mg 17β‐estradiol)
Number of subjects: 244

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 244
Study: 20668840

Group type: EXPERIMENTAL
Intervention: Melatonin 0.05 mg/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Melatonin 0.1 mg/kg
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Melatonin 0.15 mg/kg
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 18001879

Group type: EXPERIMENTAL
Intervention: Hydroxyzine 10 mg (HY) with alcohol 0.8 g/kg (AL)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Cetirizine 25 mg (CE) with alcohol 0.8 g/kg (AL)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Alcohol 0.8 g/kg (AL)
Number of subjects: 33
Study: 16708806

Group type: EXPERIMENTAL
Intervention: Ulinastatin (1 x 10(4) U/kg intravenously before CPB and added to primary solution)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ulinastatin
Number of subjects: 30

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 30
Study: 12562974

Group type: EXPERIMENTAL
Intervention: Homeopathic arnica 30C
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Homeopathic arnica 6C
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 10319783

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 24

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 24
Study: 8946663

Group type: EXPERIMENTAL
Intervention: Enoxacin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 6
Study: 1773412

Group type: EXPERIMENTAL
Intervention: 50 mL of ioversol 320 (16 g iodine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 75 mL of ioversol 320 (24 g iodine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 100 mL of iohexol 240 (24 g iodine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 100 mL of iohexol 300 (30 g iodine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 150 mL of iohexol 240 (36 g iodine)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Overall conclusion from the study
Number of subjects: 100
Study: 6182834

Group type: EXPERIMENTAL
Intervention: d‐Tubocurarine
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: succinylcholine
Number of subjects: 105

Group type: COMPARATOR
Intervention: alcuroium
Number of subjects: 105

Group type: COMPARATOR
Intervention: gallamine
Number of subjects: 105

Group type: COMPARATOR
Intervention: pancuronium
Number of subjects: 105
Study: 31350646

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT) administered to 676 patients (82.7%)
Number of subjects: 817

Group type: COMPARATOR
Intervention: No Radiotherapy (RT) administered to 141 patients (17.3%)
Number of subjects: 817

Group type: EXPERIMENTAL
Intervention: Radiotherapy (RT)
Number of subjects: 817
Study: 30535218

Group type: EXPERIMENTAL
Intervention: Mexiletine (600 mg daily)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Mexiletine
Number of subjects: 30
Study: 26935138

Group type: EXPERIMENTAL
Intervention: 8 KKW
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: 4 KKW
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: 12 KKW
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: CWL
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: MWL
Number of subjects: 330

Group type: COMPARATOR
Intervention: Neither
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: CWL and MWL
Number of subjects: 330
Study: 24935072

Group type: EXPERIMENTAL
Intervention: ticagrelor 90 mg bid
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: ticagrelor 45 mg bid
Number of subjects: 139

Group type: COMPARATOR
Intervention: clopidogrel 75 mg qd
Number of subjects: 139
Study: 23264238

Group type: EXPERIMENTAL
Intervention: Diabetes Mellitus (DM)
Number of subjects: 4144

Group type: EXPERIMENTAL
Intervention: Revascularisation treatment
Number of subjects: 4144

Group type: EXPERIMENTAL
Intervention: Conservative treatment
Number of subjects: 4144
Study: 19601492

Group type: EXPERIMENTAL
Intervention: 2% lidocaine with 1:2500 phenylephrine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2% mepivacaine with 1:100,000 adrenaline
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 60
Study: 17452542

Group type: EXPERIMENTAL
Intervention: Migraine
Number of subjects: 20084
Study: 15302800

Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg) daily for 6 months
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 11967252

Group type: EXPERIMENTAL
Intervention: Celecoxib, 200 mg twice daily (n=91)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo (n=87)
Number of subjects: 178